Conservative and Surgical Modalities in the Management of Pediatric Parapneumonic Effusion and Empyema
CHEST · 2023-11 · 164 (5) · 1125-1138
DOI: 10.1016/j.chest.2023.06.010 ↗Kurz gefasst
Netzwerk-Metaanalyse in der Zeitschrift CHEST, 2023-11. Verfasst von Clara Fernandez Elviro und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respiratory Medicine, Department of Pediatrics, British Columbia Children's Hospital, Vancouver, BC, Canada; Department Woman-Mother-Chil…. Hauptthemen laut MEDLINE: Community-Acquired Infections, Empyema, Pleural, Pleural Effusion, Pneumonia. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: School of Public Health, Imperial College London, Benha University.
Abstract (Originalsprache)
BACKGROUND: The optimal treatment for community-acquired childhood pneumonia complicated by empyema remains unclear. RESEARCH QUESTION: In children with parapneumonic effusion or empyema, do hospital length of stay and other key clinical outcomes differ according to the treatment modality used? STUDY DESIGN AND METHODS: A living systematic review of randomized controlled trials (RCTs) was conducted by searching the Cochrane Central Register of Controlled Trials, Embase, Latin American and Caribbean Health Sciences Literature, Ovid MEDLINE, and Web of Science Core Collection databases. Eligible RCTs included patients aged < 18 years and compared two of the following treatment modalities: antibiotics alone, chest tube insertion with or without fibrinolytics, video-assisted thoracoscopic surgery (VATS), and decortication via thoracotomy. A network meta-analysis was performed to evaluate treatment effects on hospital length of stay (LOS), the primary outcome. RESULTS: Eleven trials including a total of 590 patients were selected for the network meta-analysis. Compared with a chest tube alone, a chest tube with fibrinolytics, thoracotomy, and VATS were all associated with shorter LOS, with a mean difference of 5.05 days (95% CI, 2.46-7.64), 6.33 days (95% CI, 3.17-9.50), and 5.86 days (95% CI, 3.38-8.35), respectively. No substantial differences in LOS were observed between the latter three interventions. None of the 11 RCTs compared antibiotics alone vs other types of treatment. Most trials reported peri-procedural complications and the need for reintervention, but the descriptions differed significantly between trials, preventing meta-analysis. In trials reporting health care-associated costs, fibrinolytics had cost advantages compared with VATS. Short- and long-term morbidity and mortality were very low, regardless of the treatment modality. INTERPRETATION: The results of this network meta-analysis showed that a chest tube alone was associated with a longer LOS compared with other treatment modalities. The lower cost associated with a chest tube plus fibrinolytics warrants consideration when choosing between treatment options, given similar LOS and clinical outcomes compared with the other modalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Respiratory Medicine, Department of Pediatrics, British Columbia Children's Hospital, Vancouver, BC, Canada; Department Woman-Mother-Child, Service of Paediatrics, Paediatric Pulmonology and Cystic Fibrosis…
- Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
- Faculty of Medicine, University of Calgary, Calgary, AB, Canada.
- Unit of Innovation and Organization, Navarre Institute for Health Research (IdiSNA), Pamplona, Spain.
- Vancouver-Fraser Medical Program, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada.
- British Columbia Children's Hospital Research Institute, Vancouver, BC, Canada.
Förderung
- School of Public Health
- Imperial College London
- Benha University
- University of British Columbia
Zitieren
APA
Fernandez Elviro, C., Longcroft-Harris, B., Allin, E., Leache, L., Woo, K., Bone, J. N., Pawliuk, C., Tarabishi, J., Carwana, M., Wright, M., Nama, N., & InsightScope Team (2023). Conservative and Surgical Modalities in the Management of Pediatric Parapneumonic Effusion and Empyema. CHEST, 164(5), 1125-1138. https://doi.org/10.1016/j.chest.2023.06.010
Vancouver
Fernandez Elviro C, Longcroft-Harris B, Allin E, Leache L, Woo K, Bone JN, et al. Conservative and Surgical Modalities in the Management of Pediatric Parapneumonic Effusion and Empyema. CHEST. 2023;164(5):1125-1138. doi:10.1016/j.chest.2023.06.010
BibTeX
@article{FernandezElviro2023,
author = {Fernandez Elviro, Clara and Longcroft-Harris, Bryn and Allin, Emily and Leache, Leire and Woo, Kellan and Bone, Jeffrey N and Pawliuk, Colleen and Tarabishi, Jalal and Carwana, Matthew and Wright, Marie and Nama, Nassr and InsightScope Team, InsightScope Team},
title = {Conservative and Surgical Modalities in the Management of Pediatric Parapneumonic Effusion and Empyema},
journal = {CHEST},
year = {2023},
volume = {164},
number = {5},
pages = {1125--1138},
doi = {10.1016/j.chest.2023.06.010}
}
EUVIMED